Invention Grant
- Patent Title: Monoclonal antibodies against HER2 epitope
-
Application No.: US15627921Application Date: 2017-06-20
-
Publication No.: US10793640B2Publication Date: 2020-10-06
- Inventor: Bart De Goeij , Edward N. Van Den Brink , Simone De Haij , Thilo Riedl , Rene Hoet , Ole Baadsgaard , David Satijn , Jan Van De Winkel , Paul Parren
- Applicant: GENMAB A/S
- Applicant Address: DK Copenhagen V
- Assignee: GENMAB A/S
- Current Assignee: GENMAB A/S
- Current Assignee Address: DK Copenhagen V
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Christopher L. Frank
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@7117734d
- Main IPC: C07K16/30
- IPC: C07K16/30 ; A61K39/395 ; C07K16/32 ; A61K39/00
Abstract:
Isolated monoclonal antibodies which bind to human epidermal growth factor receptor 2 (HER2), and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies are also disclosed.
Public/Granted literature
- US20180022816A1 MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE Public/Granted day:2018-01-25
Information query
